Financials in USD. Standardized financial statements.
A compact view of how Science 37 Holdings, Inc. turns revenue into operating income and net income.
| Metric | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Revenue? | $70.15M | $59.60M | $23.70M | $0 |
| Revenue Growth? | +17.7% | +151.4% | 0.0% | 0.0% |
| Cost of Revenue? | $54.28M | $42.39M | $22.60M | $0 |
| Gross Profit? | $15.87M | $17.20M | $1.11M | $0 |
| Gross Margin? | +22.6% | +28.9% | +4.7% | 0.0% |
| Operating Expenses? | $121.20M | $80.92M | $32.80M | $0 |
| Operating Income? | -$105.33M | -$63.72M | -$31.69M | $0 |
| EBITDA? | -$139.41M | -$24.62M | -$26.47M | $0 |
| Income Before Tax | -$51.08M | -$94.33M | -$31.67M | -$1,000 |
| Income Tax Expense | -$90,000 | $1,000 | $695,000 | $0 |
| Net Income? | -$50.99M | -$94.33M | -$32.37M | -$1,000 |
| EPS? | $-0.44 | $-2886.59 | $-2.18 | $-0.00 |
| Diluted EPS? | $-0.44 | $-2886.59 | $-2.18 | $-0.00 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality